CME GROUP INC. CME Cash Flow

Cme group inc. (CME)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09	Dec'08	Dec'07
Cash Flows from Operating Activities
Net Income
2,115,800	1,963,700	4,063,400	1,534,100	1,247,000	1,126,900	978,100	906,700	1,814,400	952,100	825,800	715,500	658,500
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation
73,100	96,500	58,000	66,200	60,800	54,800	54,400	61,400	51,300	40,900	33,400	37,600	22,900
Amortization of shares issued to Board of Directors
-	-	-	-	-	-	-	-	-	-	-	-	1,800
Amortization of Intangible Assets
314,700	130,000	95,500	96,100	99,400	100,600	103,000	116,200	132,000	128,100	125,100	98,700	33,900
Depreciation and amortization
158,600	118,700	113,000	129,200	129,200	132,600	135,100	136,900	128,500	129,900	126,300	137,300	105,700
Net losses on assets held for sale and impaired
61,100	0	0	27,100	0	0	-	-	-	-	-	-	-
Gain on sale of BM&FBOVESPA Shares
-	-	-	48,400	-8,500	0	0	-	-	-	-	-	-
Gain on sale of Bolsa Mexicana de Valores, S.A.B. de C.V.
-	-	-	0	0	-	-	-	-	-	-	-	-
Income tax expense reclassified from accumulated other comprehensive income upon final sale of BM&FBOVESPA shares
0	0	-87,800	0	0	-	-	-	-	-	-	-	-
Change in net unrealized securities gains
-	-	-	-	-	-	-	-	-	-	41,900	-41,700	3,100
Net loss on derivative contracts
-17,700	-62,300	0	0	-	-	-	-	-	-	-	-	-
Net realized and unrealized (gains) losses on investments
-1,800	97,400	88,800	0	-	-	-	-	-	-	-	-	-
Gains (Losses) on Extinguishment of Debt
-	-	-	-	-61,800	0	0	-	-	-	-	-	-
Net loss on derivative investments
-	-	-	-	-	-	-	-	-	-8,600	0	8,100	-100
Impairment of goodwill and intangible assets
-	-	-	-	-	-	-	-	-	20,500	0	14,100	0
Loss on sale of metals trading products
-	-	-	-	-	-	-	-	-	-	-	-	0
Impairment of securities lending assets
-	-	-	-	-	-	-	-	-	-	-	24,300	0
Impairment of long-term investments
-	-	-	-	-	-	-	-	-	2,200	46,000	274,500	0
MF Global accounts receivable write-off
-	-	-	-	-	-	-	-	21,700	0	0	-	300
Recognition of in-process research and development acquired from Credit Market Analysis Limited
-	-	-	-	-	-	-	-	-	-	-	3,700	0
Net accretion of discounts and amortization of premiums on marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	1,100
Amortization of debt financing costs and discount accretion
-	-	-	-	-	-	-	-	-	4,900	12,700	9,700	1,400
Gain on sale of Index Services assets
-	-	-	-	-	-	-	-	9,800	0	0	-	-
Gain on contribution of Dow Jones Index asset group
-	-	-	-	-	-	-	78,800	0	0	-	-	-
Loss on sale of Credit Market Analysis Ltd.
-	-	-	-	-	-	-	-19,900	0	0	-	-	-
Gain (Loss) on Sale of Property Plant Equipment
-	-	-	-	-	-	-27,100	0	0	-	-	-	-
Undistributed net earnings of unconsolidated subsidiaries
43,600	8,300	26,800	2,300	5,100	8,600	2,000	15,800	-4,300	-	-	-	-
Guarantee of exercise right privileges
-	-	-	-	-	-	-	-	-	-	4,300	12,800	-17,200
Equity in net (gains) losses of unconsolidated subsidiaries
-	-	-	-	-	-	-	-	-	-6,400	-6,800	31,500	-14,000
Deferred income taxes
-3,700	114,300	-2,445,600	-83,000	63,300	78,900	-6,000	82,200	-658,700	22,300	-56,900	-115,100	-50,600
Change in:
Accounts receivable
-60,800	65,500	-6,000	8,100	17,300	38,500	35,500	300	13,200	28,700	14,400	-81,300	49,900
Other current assets
-110,200	84,900	26,100	-1,200	12,700	-3,700	2,600	18,200	69,400	29,900	7,400	-6,400	-8,000
Other assets
-29,200	-29,700	77,100	3,400	4,000	11,500	-600	65,600	27,100	2,900	6,900	48,600	1,300
Accounts payable
-54,100	32,300	5,100	-2,600	-8,200	700	-5,500	11,200	-21,000	6,100	-24,300	24,000	4,600
Income taxes payable
-28,600	195,400	3,500	60,500	-82,100	-105,600	-9,300	71,900	-18,000	12,400	13,800	-22,800	23,600
Other current liabilities
-99,300	-36,800	-8,900	-12,400	-3,900	-46,100	42,500	-5,600	-6,600	79,600	-23,300	-96,300	14,000
Other liabilities
-52,800	-20,500	-8,500	-22,500	-9,800	-2,800	-5,500	-7,300	13,200	5,300	30,700	25,900	11,300
Other
-11,900	-11,300	-600	-300	-5,600	-6,300	-6,100	-4,900	-4,700	-1,800	0	200	-
Net Cash Provided by (Used in) Operating Activities
2,672,800	2,440,800	1,751,100	1,732,000	1,532,500	1,291,400	1,280,500	1,219,700	1,346,300	1,359,600	1,083,100	1,197,200	814,400
Cash Flows from Investing Activities
Proceeds from maturities of available-for-sale marketable securities
18,800	11,800	2,500	41,700	38,300	37,500	36,500	29,500	11,300	11,900	439,800	265,100	203,800
Purchases of available-for-sale marketable securities
15,400	10,000	3,000	45,900	35,300	38,300	36,600	32,500	10,200	10,200	159,900	367,600	129,100
Purchases of property, net
245,600	116,700	81,900	91,800	114,200	140,700	125,600	141,800	172,200	160,000	157,900	200,100	163,700
Investments in business ventures
0	0	5,300	9,100	16,700	65,500	4,000	67,800	0	17,400	-	-	-
Proceeds from sale of business ventures
89,600	20,700	267,600	8,800	0	0	-	-	-	-	-	-	-
Proceeds from sale of Bm&fbovespa
-	-	-	150,000	138,800	0	0	-	-	-	-	-	-
Proceeds from sales of investments
-	-	-	0	0	-	-	-	-	-	-	-	-
Proceeds from sale of building property
-	-	-	-	-	7,900	192,400	148,600	0	0	-	-	-
Purchase of exercise right privileges
-	-	-	-	-	-	-	-	-	-	-	-	39,800
Cash acquired in merger with CBOT Holdings
-	-	-	-	-	-	-	-	-	-	-	-	116,000
Cash paid to acquire NEX, net of cash received
0	1,795,400	0	0	-	-	-	162,900	0	19,600	0	2,864,000	0
Proceeds from sale of Bolsa Mexicana de Valores, S.A.B de C.V.
-	-	-	-	-	-	-	-	-	-	-425,900	-110,100	0
Loans and Leases Receivable, Related Parties, Additions
-	-	-	-	-	-	-	0	-	-	-	-	-
Proceeds from sale of Credit Market Analysis Ltd., net of cash sold with business
-	-	-	-	-	-	-	42,400	0	0	-	-	-
Proceeds from sale of Index Services assets
-	-	-	-	-	-	-	-	18,000	0	0	-	-
Proceeds from sale of metals trading products
-	-	-	-	-	-	-	-	-	-	-	25,700	0
Investment in DME Holdings Limited
-	-	-	-	-	-	-	-	-	-	0	-	-
Acquisition of NYMEX Holdings, net of cash received
-	-	-	-	-	-	-	-	-	-	-	-	0
NYMEX membership rights payment
-	-	-	-	-	-	-	-	-	-	-	612,000	0
Proceeds from sale of long-term investment
-	-	-	-	-	-	-	-	-	47,200	0	-	-
Merger-related transaction costs
-	-	-	-	-	-	-	-	-	-	-	50,900	43,900
Purchase of derivative related to BM&FBOVESPA SA investment
-	-	-	-	-	-	-	-	-	-	-	45,200	0
Proceeds from Chicago Board Options Exchange exercise right privileges
-	-	-	-	-	-	-	-	-	39,700	0	-	-
Settlement of derivative related to debt issuance
-	-	-	-	-7,000	0	-127,800	24,400	0	3,200	-	-	-
Capital contributions to FXMarketSpace Limited
-	-	-	-	-	-	-	-	-	-	3,100	10,200	19,000
Other
-	-	-	-	-	-	-	-	500	0	0	-	3,000
Net Cash Used in Investing Activities
-152,600	-1,889,600	179,900	53,700	17,900	-199,100	190,500	-208,900	-153,600	-111,600	544,800	-3,749,100	-78,700
Cash Flows from Financing Activities
Proceeds from Issuance of Commercial Paper, net of issuances
-92,500	386,900	0	0	-	-	-	-	-	-99,900	-1,393,600	1,330,300	162,900
Proceeds from other borrowings, net of issuance costs
0	1,185,000	0	0	743,700	0	748,700	747,700	0	608,000	743,500	2,881,900	0
Repayment of other borrowings
569,200	452,500	0	0	673,000	750,000	750,000	0	420,500	300,000	250,000	1,282,900	0
Net change in NYMEX securities lending program liabilities
-	-	-	-	-	-	-	-	-	-	456,800	110,100	0
Cash dividends
1,695,900	2,149,900	1,993,500	1,787,200	1,343,400	1,496,800	599,100	1,224,300	372,800	305,300	305,600	615,200	151,600
Premium payment for derivative contract
-	-	-	0	-	-	-	-	-	-	-	-	-
Settlement of derivative contracts
-16,000	30,000	0	-	-	-	-	-	-	-	-	-	-
Class A common stock issued to BM&FBOVESPA SA
-	-	-	-	-	-	-	-	-	607,100	0	-	-
Stock issuance costs in merger with NYMEX Holdings
-	-	-	-	-	-	-	-	-	-	-	9,100	16,000
Repurchase of Class A common stock, including costs
-	-	-	-	-	-	-	-	220,400	575,300	27,000	224,000	949,300
Proceeds from exercise of stock options
-	-	-	51,800	64,000	53,300	73,700	22,100	5,800	12,600	20,400	20,500	39,100
Proceeds from lease financing obligation
-	-	-	130,000	0	0	-	-	-	-	-	-	-
Distribution paid to non-controlling interest
-	-	-	-	-	4,700	80,000	0	0	607,500	0	-	-
Excess tax benefits related to employee option exercises and restricted stock vesting
-	-	-	9,500	7,100	4,000	6,800	4,600	600	5,800	2,500	11,600	53,700
Employee taxes paid on restricted stock vesting
36,800	35,000	31,300	26,800	17,200	-	-	-	-	-	-	-	-
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
-	-	-	-	-7,000	-3,600	-7,300	0	-	-	-	-	-
Contingent Consideration Settlement
-	-	-	-	-	-	-	-	0	-	-	-	-
Other
37,600	15,500	39,500	2,200	1,900	1,900	1,200	1,500	1,700	1,100	1,400	1,500	-
Proceeds from Employee Stock Purchase Plan
-	-	-	-	-	-	-	-	-	-	-	-	1,300
Net Cash Used in Financing Activities
-2,340,800	-1,080,000	-1,985,300	-1,620,500	-1,223,900	-2,195,900	-606,000	-448,400	-1,005,600	-653,400	-1,665,200	2,004,500	-859,900
Net change in cash, cash equivalents and restricted cash
179,400	-528,800	-54,300	165,200	326,500	-1,103,600	865,000	562,400	187,100	594,600	-37,300	-547,400	-124,200
Supplemental Disclosure of Cash Flow Information
Income taxes paid
591,200	577,400	762,800	706,700	716,600	641,500	612,200	624,400	816,100	765,900	629,700	665,400	413,700
Interest paid
146,300	108,300	84,800	84,800	89,100	111,400	133,400	110,600	111,900	104,900	90,800	21,100	2,000
Non-cash investing activities:
Common stock issued for acquisition of NEX
0	3,105,800	0	0	-	-	-	878,400	0	0	-	-	-
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax
-	-	-	-	-	-	-	-25,300	0	-9,700	12,200	-34,300	0
Dividends declared
893,700	624,400	1,187,300	1,099,300	977,100	670,900	868,000	0	0	-	-	-	-
Fair value of Class A common stock, stock options and restricted stock units issued in connection with NYMEX Holdings merger
-	-	-	-	-	-	-	-	-	-	-	5,963,300	0
Fair value of Class A common stock issued in exchange for BM&FBOVESPA SA stock
-	-	-	-	-	-	-	-	-	-	-	631,400	0
Fair value of Class A common stock and stock options issued in connection with CBOT Holdings merger
-	-	-	-	-	-	-	-	-	-	-	-	11,144,800